Home
Monoclonal antibodies
Our website provide antibody services including production of monoclonal antibodies. We can produce your monoclonal antibodies with our hybridoma technology. We provides antibodies monoclonal at a low rate.
Monoclonal antibodies production services
Monoclonal antibody by admin - 03-24-2012
Monoclonal Antibody
Monoclonal antibody can be made by hybridoma technology, fusing myeloma cells with the spleen cells from a mouse that has been immunized with the desired antigen.- Immunization (5 mice/antigen) and Sera Testing by ELISA
- Fusion and Colony Screening
- Subcloning, Colony Expansion and Freezing
- Guaranteed western blot positive clones (2 clones)
- Antibody Purification from Ascites by Protein A/G (2 clones, 3mg each)
Antibody production by admin - 03-24-2012
Antibody production
Monoclonal antibodies provide single epitope specificity and potentially limitless amounts of identical antibody. In our website we can provide you a complete package of monoclonal antibody production. In this package in addition of producing the antibodies monoclonal, we included the antigen production.Complete package - protein production (antigen) + antibodies monoclonal production by hybridoma technology
- Recombinant protein production (antigen production)
- Immunization (5 mice/antigen) and Sera Testing by ELISA
- Fusion and Colony Screening
- Subcloning, Colony Expansion and Freezing
- Guaranteed western blot positive clones (2 clones)
- Antibody Purification from Ascites by Protein A/G (2 clones, 3mg each)
More about monoclonal antibodies
Video about monoclonal antibody production
Video explaining monoclonal antibody production
Relating websites:
- Visit our other websites relating to monoclonal antibodies, production of monoclonal antibodies, antibody, antibody production, hybridoma, and antibodies monoclonal.
- Visit our company website at www.vrisko.net.
News
Antibody production
New cell line development for antibody-producing Chinese hamster ovary cells ...
7thSpace Interactive (press release)
Conclusions: This study proved that the fragment complementation for split GFP could be an efficient indication for antibody production on the basis of high correlation of qAb with reconstitution of GFP. Taken together, we developed an efficient ...Biologists Produce Potential Malarial Vaccine from Algae
Science Daily (press release)
The use of algae to produce malaria proteins that elicited antibodies against Plasmodium falciparum in laboratory mice and prevented malaria transmission was published May 16 in the online, open-access journal PLoS ONE. The development resulted from an ...Australian Institute for Bioengineering and Nanotechnology and Biosceptre ...
Nanowerk LLC
(Nanowerk News) UniQuest, The University of Queensland's (UQ) main commercialisation company, has facilitated a strategic research collaboration and antibody production agreement between Australian Institute for Bioengineering and Nanotechnology (AIBN) ...CytoDyn completes production of FIV monoclonal antibodies
Pharmaceutical Business Review
CytoDyn has completed the production of an adequate amount of CytoFeline to allow CytoDyn Veterinary Medicine (CVM) to move forward with next stage of research. CytoFeline is a monoclonal antibody developed for the treatment of Feline Immunodeficiency ...Intellect Neurosciences Expands Its Immunotherapy Pipeline with New Technology ...
MarketWatch (press release)
Company Files Three Patent Applications for Methods of Diagnosis and Treatment of Neurodegenerative Diseases Based on Production of Antibodies, and Vaccines that Selectively Target the Earliest Forms of Neurotoxic Proteins. NEW YORK, May 16, ...Intellect Neurosciences Expands Its Immunotherapy Pipeline with New Technology ...
PharmaLive.com (press release)
Company Files Three Patent Applications for Methods of Diagnosis and Treatment of Neurodegenerative Diseases Based on Production of Antibodies, and Vaccines that Selectively Target the Earliest Forms of Neurotoxic Proteins. NEW YORK, May 16, ...Theraclone Sciences Announces Positive Top-line Data from a Phase 1 Trial of ...
MarketWatch (press release)
SEATTLE, May 15, 2012 (BUSINESS WIRE) -- Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, today announced positive top-line data from its Phase 1 trial of TCN-032, a broadly protective, fully human monoclonal ...Vrisko Limited Announces Agreement with ABM, a Canadian Company Leader in ...
Free Press Release Center (press release)
Vrisko Limited is happy to announce that reached a distribution agreement with ABM, a Canadian company leader in antibody production including polyclonal- and monoclonal antibodies. April 21, 2012 (FPRC) -- Vrisko Limited is happy to announce that ...Successful Immunization and Safety Documented in Nasal Administration Study of ...
MarketWatch (press release)
Dose-related differences are currently under evaluation, and additional data including antibody production in mucosal secretions will be analyzed and published at a later stage. The results are furthermore documenting safety by nasal administration of ...Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody ...
MarketWatch (press release)
ALD403 is manufactured with our Mab Xpress technology which allows us to mass produce the antibody for large markets, such as migraine and to rapidly achieve proof of concept. Research has shown that CGRP has a role as a trigger for migraine attacks, ...